Biomarkers for Idiopathic Pulmonary Fibrosis
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 7458
Special Issue Editor
Interests: immunology; flow cytometry; allergy; biomarkers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease, characterized by fibrosis and respiratory failure. The diagnosis and prognosis of IPF patients required a combination of imaging, clinical and laboratory findings. Despite the progression in the understanding of pathogenesis, disease onset, progression and response to treatment cannot be reliably predicted. To date, no specific marker has been approved for the clinical management of IPF patients. Thus, non-invasive biomarkers (e.g., in serum, bronchoalveolar lavage (BAL), saliva and urine) are urgently needed to investigate IPF pathogenesis and its genetic predisposition, as well as their utility for diagnosis, differential diagnosis, prognosis, and prediction of therapeutic response. Additionally, it could be interesting to focus on the novel biological matrix in order to investigate biomarkers, including cell culture, genomic assay, microbiome analysis. The upcoming Special Issue of Biomedicines is now calling for submissions of original research articles, brief reports and review articles focusing on biomarkers in the field of idiopathic pulmonary fibrosis.
Dr. Miriana d'Alessandro
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- idiopathic pulmonary fibrosis
- immunology
- diagnosis
- prognosis
- therapy